Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,974 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase II trial.
Yoshino T, Hasegawa Y, Takahashi S, Monden N, Homma A, Okami K, Onozawa Y, Fujii M, Taguchi T, de Blas B, Beier F, Tahara M. Yoshino T, et al. Among authors: taguchi t. Jpn J Clin Oncol. 2013 May;43(5):524-31. doi: 10.1093/jjco/hyt034. Epub 2013 Mar 10. Jpn J Clin Oncol. 2013. PMID: 23479384 Free PMC article. Clinical Trial.
Randomized phase III trial of adjuvant chemotherapy with S-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (ACTS-HNC).
Tsukahara K, Kubota A, Hasegawa Y, Takemura H, Terada T, Taguchi T, Nagahara K, Nakatani H, Yoshino K, Higaki Y, Iwae S, Beppu T, Hanamure Y, Tomita K, Kohno N, Kawabata K, Fukushima M, Teramukai S, Fujii M; ACTS-HNC group. Tsukahara K, et al. Among authors: taguchi t. PLoS One. 2015 Feb 11;10(2):e0116965. doi: 10.1371/journal.pone.0116965. eCollection 2015. PLoS One. 2015. PMID: 25671770 Free PMC article. Clinical Trial.
Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Kubota A, Nakatani E, Tsukahara K, Hasegawa Y, Takemura H, Terada T, Taguchi T, Nagahara K, Nakatani H, Yoshino K, Higaki Y, Iwae S, Beppu T, Hanamure Y, Tomita K, Kohno N, Kawabata K, Teramukai S, Fujii M; ACTS-HNC Study Group. Kubota A, et al. Among authors: taguchi t. PLoS One. 2018 Jun 8;13(6):e0198391. doi: 10.1371/journal.pone.0198391. eCollection 2018. PLoS One. 2018. PMID: 29883463 Free PMC article. Clinical Trial.
Antiemetic effects of granisetron and dexamethasone combination therapy during cisplatin-containing chemotherapy for head and neck cancer: dexamethasone dosage verification trial.
Tsukuda M, Ishitoya J, Mikami Y, Matsuda H, Katori H, Horiuchi C, Kimura M, Taguchi T, Yoshida T, Nagao J, Sakuma Y, Toth G. Tsukuda M, et al. Among authors: taguchi t. Int J Clin Oncol. 2009 Aug;14(4):337-43. doi: 10.1007/s10147-008-0874-z. Epub 2009 Aug 25. Int J Clin Oncol. 2009. PMID: 19705245 Clinical Trial.
2,974 results